Insulin resistance and elevated C-reactive protein among first-degree relatives of ischemic stroke patients

Krishnamoorthy Srilatha1, Zachariah Bobby1, D K Subrahmanyam2

  • 1Department of Biochemistry, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, 605006, India.

Insights

First-degree relatives of ischemic stroke patients show increased risks for atherosclerosis, including dyslipidemia and insulin resistance. Early screening for these conditions in family members can help prevent future vascular events.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Genetics and Stroke Risk

Background:

  • Family history is a significant non-modifiable risk factor for ischemic stroke.
  • Atherosclerosis and thrombosis are key mechanisms in cardiovascular disease and stroke.
  • Identifying at-risk individuals through family screening is crucial.

Purpose of the Study:

  • To evaluate atherosclerotic risk factors in first-degree relatives of ischemic stroke patients.
  • To compare these risk factors against a control group.

Main Methods:

  • Recruited 40 first-degree relatives (30-50 years) of ischemic stroke patients.
  • Recruited 40 age/gender-matched healthy controls without major risk factors.
  • Analyzed blood for lipids, fasting insulin, high-sensitivity C-reactive protein (hs-CRP), and homocysteine.

Main Results:

  • Relatives exhibited dyslipidemia (high total cholesterol, LDL, non-HDL), hyperinsulinemia, and insulin resistance.
  • Relatives had significantly higher hs-CRP levels (p=0.045).
  • Positive correlation found between fasting insulin, HOMA-IR, and hs-CRP in relatives.

Conclusions:

  • First-degree relatives of ischemic stroke patients present with hyperinsulinemia, insulin resistance, and dyslipidemia.
  • Insulin resistance contributes to low-grade inflammation (elevated hs-CRP), promoting atherosclerosis.
  • Screening relatives for insulin resistance and dyslipidemia may aid in preventing adverse vascular events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
651
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
615
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
471
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
810
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512